— Know what they know.
Not Investment Advice
Also trades as: NVACF (OTC) · $vol 0M

NOVC.TO TSX

Nova Cannabis Inc.
1W: +1.7% 1M: +1.2% 3M: +38.9% 1Y: +173.4% 3Y: -42.4%
C$1.74
Last traded 2024-10-22 — delisted
TSX · Healthcare · Medical - Pharmaceuticals · C$108.0M mcap · 13M float · 0.764% daily turnover

Income Trends

Revenue
$259M +14.5% ▲
5Y CAGR: +93.5%
Gross Profit
$50M +14.5% ▲
5Y CAGR: +39.4%
Operating Income
$10M +231.4% ▲
Net Income
$3M +127.0% ▲
EPS (Diluted)
$0.05 +126.4% ▲
EBITDA
$19M +417.7% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$9M$21M$134M$226M$259M
YoY Growth-10.7%+146.1%+539.2%+68.5%+14.5%
Cost of Revenue$6M$15M$109M$183M$209M
Gross Profit$3M$6M$25M$44M$50M
Gross Margin31.6%30.4%18.5%19.4%19.4%
R&D Expenses$0$0$0$0$0
SG&A Expenses$4M$13M$28M$32M$38M
Operating Expenses$7M$13M$38M$48M$40M
Operating Income-$5M-$6M-$18M-$8M$10M
Operating Margin-56.0%-30.1%-13.4%-3.3%3.8%
Interest Expense$680K$906K$0$4M$5M
Income Before Tax-$6M-$9M-$21M-$11M$3M
Tax Expense-$3M-$1M$3M$4M$11M
Net Income-$3M-$9M-$21M-$11M$3M
Net Margin-31.6%-44.1%-15.3%-4.9%1.2%
EPS (Diluted)$-0.42$-1.28$-0.39$-0.20$0.05
EBITDA-$3M$6M-$7M$4M$19M
Shares Outstanding6M7M52M57M57M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms